India’s Burmans Return To Trial Outsourcing With OneQuest
This article was originally published in PharmAsia News
The Burman family, formerly of India's Dabur Pharma, is considering a return to the medical business with its privately held company, OneQuest. The firm plans to provide molecular diagnostics for the world's major drug-research and outsourced clinical-trial companies in all therapeutic areas. OneQuest has been focusing its business on test services for oncological clinical trials. Sources say OneQuest also plans eventually to conduct trials itself. The diagnostics business used to be a part of Dabur Pharma, but was transferred to OneQuest before Fresenius Kabi bought Dabur. (Click here for more
You may also be interested in...
Procter & Gamble, through its UK wellness subsidiary Nature's Best, is on-trend with new vegan vitamin D3 and iron supplements. Nature's Best has also launched three other vitamin D3 products in the country, as well as an ashwagandha supplement.
The MHRA has updated its guidance on regulatory flexibilities for medical devices and medicinal products resulting from COVID-19 to highlight how its approach differs from the EU.
The Swiss company is planning a US trial of CBSO, the first transcatheter septal occluder with a bioresorbable, metal-free frame.